Skip to main content
HairCited

Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment.

Shuting Chen, Ling Li, Wei Ding, Yueqian Zhu, Naihui Zhou
Review Drug design, development and therapy 2025 7 citas
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D40873858'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Tipo de estudio
narrative review
Intervención
Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment. not specified
Comparador
Placebo
Dirección del efecto
Positive
Riesgo de sesgo
Unclear

Abstract

Androgenetic Alopecia (AGA) is a common type of alopecia. The pathogenesis of AGA involves genetic predisposition, androgen metabolism, inflammation, fibrosis, and impaired energy metabolism. The choice of therapeutic agents for the treatment of AGA remains controversial globally, with finasteride and minoxidil being the only two widely recognized and legally approved therapeutic options. In recent years, significant progress has been made in the development of drugs targeting different pathogenic mechanisms of AGA. This article reviews the main drugs currently used for AGA treatment. By summarizing their mechanisms of action and clinical efficacy, it aims to provide a comprehensive theoretical basis and clinical reference for the treatment of AGA.

Used In Evidence Reviews

Similar Papers